The Preliminary Effects of Capsaicin Supplementation on Cerebrovascular Function and Cognition in Middle-Aged and Older Adults Who Are Overweight or Obese
5 affiliations
- 1School of Health, Psychological and Medical Sciences, University of Southern Queensland, Ipswich, QLD 4305, Australia
- 2Institute for Health, University of Southern Queensland, Ipswich, QLD 4305, Australia
- 3Rural Clinical School, Medical School, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Toowoomba, QLD 4350, Australia
- 4School of Business, Law, Humanities and Pathways, University of Southern Queensland, Toowoomba, QLD 4350, Australia
- 5First Nations Portfolio, University of Southern Queensland, Toowoomba, QLD 4350, Australia
Abstract
Background/Objectives: Cerebrovascular function and cognition decline with age and may be further exacerbated by obesity. Capsaicin may improve cerebrovascular function and cognition, although evidence in humans is lacking. We investigated the effects of 12 weeks of capsaicin supplementation on cerebrovascular function and cognition in middle-aged and older adults who were overweight or obese. Methods: Forty participants were randomly allocated to receive 200 mg/day of Capsifen® or a placebo, with 34 completing the intervention (n = 17 in both). Before and after supplementation, transcranial Doppler ultrasonography was used to measure the cerebrovascular responsiveness (CVR) to physiological (hypercapnia, 5% carbon dioxide) and cognitive stimuli, while cognition was assessed using a comprehensive cognitive battery. The trial was prospectively registered (ACTRN12623000556640). Results: Total CVR to cognitive stimuli increased following Capsifen® supplementation (18 ± 3% to 21 ± 1%) and decreased in the placebo group (21 ± 4% to 19 ± 3%; p = 0.0002). Total cognition increased following Capsifen® supplementation (98 ± 18 to 107 ± 18) compared with the placebo (105 ± 13 to 106 ± 10; p = 0.0085). Capsifen® did not alter CVR to hypercapnia (30 ± 18% to 44 ± 27% vs. 39 ± 23% to 32 ± 16%; p = 0.5981). Working memory, executive function and exercise performance also improved, while waist circumference and waist-to-hip ratio decreased. Conclusions: Twelve weeks of Capsifen® supplementation improved total cognition and CVR to cognitive stimuli but not CVR to hypercapnia. These findings provide preliminary evidence that chronic capsaicin supplementation may improve cognition and neurovascular coupling in humans.
Related
- A pilot randomized controlled trial of melatonin supplementation on plasma 2-arachidonoylglycerol, ghrelin, and hedonic appetite intensity in females with overweight/obesity
- Effects of Bioactive Compound Supplementation on Insulin Resistance and Systemic Inflammation in Overweight and Obese Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- Effects of High-Intensity Interval Training Combined with Green Tea Supplementation on Oxidative Balance and Muscular Performance in Overweight Older Men
- The Impact of Cladribine Tablets on Cognition Over One Year in Patients With Multiple Sclerosis: A Preliminary Study.
- Brachioradial Pruritus Case Misdiagnosed for a Decade: Cervical Nerve Compression and New Hypotheses for Seasonality, Capsaicin Response, and Icing
BibTeX
@article{thornton2026preliminary,
title = {{The Preliminary Effects of Capsaicin Supplementation on Cerebrovascular Function and Cognition in Middle-Aged and Older Adults Who Are Overweight or Obese}},
author = {Tammy Thornton and Emma Kim and Tahnee Downs and Dean Mills and Edward Bliss},
journal = {Nutrients},
year = {2026},
month = oct,
doi = {10.3390/nu18213613},
url = {https://www.mdpi.com/2072-6643/18/21/3613},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The Preliminary Effects of Capsaicin Supplementation on Cerebrovascular Function and Cognition in Middle-Aged and Older Adults Who Are Overweight or Obese
AU - Tammy Thornton
AU - Emma Kim
AU - Tahnee Downs
AU - Dean Mills
AU - Edward Bliss
PY - 2026
DA - 2026/10/30
JO - Nutrients
DO - 10.3390/nu18213613
UR - https://www.mdpi.com/2072-6643/18/21/3613
AB - Background/Objectives: Cerebrovascular function and cognition decline with age and may be further exacerbated by obesity. Capsaicin may improve cerebrovascular function and cognition, although evidence in humans is lacking. We investigated the effects of 12 weeks of capsaicin supplementation on cerebrovascular function and cognition in middle-aged and older adults who were overweight or obese. Methods: Forty participants were randomly allocated to receive 200 mg/day of Capsifen® or a placebo, with 34 completing the intervention (n = 17 in both). Before and after supplementation, transcranial Doppler ultrasonography was used to measure the cerebrovascular responsiveness (CVR) to physiological (hypercapnia, 5% carbon dioxide) and cognitive stimuli, while cognition was assessed using a comprehensive cognitive battery. The trial was prospectively registered (ACTRN12623000556640). Results: Total CVR to cognitive stimuli increased following Capsifen® supplementation (18 ± 3% to 21 ± 1%) and decreased in the placebo group (21 ± 4% to 19 ± 3%; p = 0.0002). Total cognition increased following Capsifen® supplementation (98 ± 18 to 107 ± 18) compared with the placebo (105 ± 13 to 106 ± 10; p = 0.0085). Capsifen® did not alter CVR to hypercapnia (30 ± 18% to 44 ± 27% vs. 39 ± 23% to 32 ± 16%; p = 0.5981). Working memory, executive function and exercise performance also improved, while waist circumference and waist-to-hip ratio decreased. Conclusions: Twelve weeks of Capsifen® supplementation improved total cognition and CVR to cognitive stimuli but not CVR to hypercapnia. These findings provide preliminary evidence that chronic capsaicin supplementation may improve cognition and neurovascular coupling in humans.
SN - 2072-6643
ER -